The Biomedical Catalyst 2019 is a funding competition that aims to support the development of innovative healthcare products, technologies and processes.
These can include (but are not limited to):
– disease prevention and proactive management of health and chronic conditions
– earlier and better detection and diagnosis of disease, leading to better patient outcomes
– tailored treatments that either change the underlying disease or offer potential cures
The Biomedical Catalyst has 4 funding strands to support progression of projects from initial concept through to late stage development: Feasibility, Primer, Early Stage, and Late Stage.
Two separate competitions are being launched this month: the first combining the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months, and a separate competition combining early and late stages. You can apply for the early and late stages without needing to go through feasibility and primer. A total of £10 million in grant funding is available across the 2 strands.
Biomedical Catalyst 2019 – Round 1: Feasibility and Primer Awards
The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system by:
– reviewing research evidence and identifying possible applications
– assessing business opportunities
– assessing and/or protecting intellectual property
– validating initial concepts and existing pre-clinical work through experimental studies
– initial demonstration using in-vitro and in-vivo models (but not human clinical trials such as safety and efficacy)
– early stage prototyping
– preliminary regulatory advice
Projects must focus on the development of a product or process that is an innovative solution to a health and care challenge.
Total funding available: £3 million
Competition opens: Monday 21 January 2019
Competition closes: Wednesday 3 April 2019, 12:00pm
Click here for full details.
Biomedical Catalyst 2019 – Round 1: Early and Late Stage Awards
The aim of this competition is to enable companies to create a data package that can support the subsequent testing of products or carry out evaluations in a clinical setting or other relevant environment. This can include:
– experimental evaluation (at laboratory scale)
– use of in vitro and in vivo models to evaluate proof of concept or safety
– exploring potential production mechanisms
– prototyping
– product development planning
– intellectual property protection
– demonstrating of clinical utility and effectiveness
– demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
– regulatory planning
Projects must focus on the development of a product or process that is an innovative solution to a health and care challenge.
This competition has 2 stages:
Stage 1: assessed written application
Stage 2: interview with Major Awards Committee
Total funding available: £7 million
Competition opens: Monday 21 January 2019
Competition closes: Wednesday 3 April 2019, 12:00pm
Click here for full details.
R&D Funding Group can advise if your business is eligible to apply for these grants and help you win funding. To find out more, please contact Stephen Dyson on 0161 464 6351 or email sdyson@rdfunding.co.uk.